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Abstract
The Scl gene encodes a transcription factor essential for haematopoietic development. Scl transcription is regulated by a
panel of cis-elements spread over 55 kb with the most distal 39 element being located downstream of the neighbouring
gene Map17, which is co-regulated with Scl in haematopoietic cells. The Scl/Map17 domain is flanked upstream by the
ubiquitously expressed Sil gene and downstream by a cluster of Cyp genes active in liver, but the mechanisms responsible
for delineating the domain boundaries remain unclear. Here we report identification of a DNaseI hypersensitive site at the 39
end of the Scl/Map17 domain and 45 kb downstream of the Scl transcription start site. This element is located at the
boundary of active and inactive chromatin, does not function as a classical tissue-specific enhancer, binds CTCF and is both
necessary and sufficient for insulator function in haematopoietic cells in vitro. Moreover, in a transgenic reporter assay,
tissue-specific expression of the Scl promoter in brain was increased by incorporation of 350 bp flanking fragments from the
+45 element. Our data suggests that the +45 region functions as a boundary element that separates the Scl/Map17 and Cyp
transcriptional domains, and raise the possibility that this element may be useful for improving tissue-specific expression of
transgenic constructs.
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Introduction
The Stem Cell Leukemia (Scl) gene, also known as Tal1,
encodes a basic helix-loop-helix transcription factor with impor-
tant roles in the development of the haematopoietic [1–3] vascular
[4,5] and central nervous systems [4,6,7]. Ectopic expression of Scl
is detrimental for the normal differentiation of the affected
lineages. For example, SCL overexpression in T-cells is one of the
most common molecular abnormalities found in T-ALL [8].
Appropriate spatio-temporal transcription of Scl is therefore
essential for the normal development and homeostasis of the
haematopoietic system and this focuses attention on the mecha-
nisms controlling Scl transcription.
In order to understand the mechanisms involved in the
regulation of Scl expression, we have systematically dissected the
cis-regulatory elements operating at the murine Scl locus.
Comparisons of Scl flanking genes during vertebrate evolution
revealed a limited region of conserved synteny, spanning the
Scl and Map17 genes, likely to contain regulatory elements
responsible for the conserved pattern of Scl expression [9,10]. A
100 kb DNA fragment encompassing the entire Scl/Map17
domain is sufficient to reproduce endogenous Scl expression and
rescue the Scl knockout phenotype [11]. The Map17 gene is
expressed in skin, liver and kidney and is co-regulated with
Scl in haematopoietic cells [12]. Studies of the chromatin structure
of the mouse Scl/Map17 locus, combined with comparative
sequence analysis and reporter assays in transgenic mice have
allowed us to characterize the Scl and Map17 promoters together
with a panel of enhancers [13]. The Scl promoters have no
hematopoietic activity and drive Scl expression in the central
nervous system [14]. Haematopoietic-specific expression is
achieved due to the presence of the tissue-specific enhancers 24,
+19 and +40 (named in kb with respect to the start of exon
1a). Each of these elements directs expression to a subdomain
of the normal Scl expression pattern in transgenic mice
[9,10,12,14–19]. In mammals the Scl/Map17 co-regulatory
domain is flanked upstream by the ubiquitously expressed Sil
gene and downstream by a battery of cytochrome genes mostly
expressed in liver, however the Cyp gene immediately down-
stream, Cyp4x, is highly expressed in brain [20]. This arrange-
ment suggests the existence of boundary mechanisms that
insulate the Scl/Map17 domain from its neighbours. In this
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element) at the telomeric end of the Scl/Map17 domain, and
demonstrate that it functions as a CTCF-dependent insulator both
in vitro and in vivo.
Methods
DNaseI hypersensitive site (HSS) mapping
Briefly, nuclei from 416B, mES cells and primary mice
thymocytes were isolated and treated with DNaseI. DNA from
treated nuclei and genomic DNA (Input) was isolated, labelled
with Cy3/Cy5 and hybridised to DNA microarrays as previously
described [21,22]. The Scl DNA microarrays were synthesised by
FlyChiP using PCR amplicons of non-repeat regions with an
average size of 500 bp as previously described. Details of PCR
amplicons are available on request. Following hybridisation, slides
were analysed as previously described.
Luciferase assays
416B cells were co-transfected with the constructs described
bellow and the PGK-Neo construct and selected for Neo
resistance. Luciferase assays were performed on selected cells as
described previously [19]. The basic constructs SV/Luc, Map17/
Luc and Scl/Luc have all been used in transfection assays
previously [15,19]. The +45 element was mapped from the HSS
experiments as 1.76 kb fragment (genomic co-ordinates, chr4:
114773516–114775283). This element was amplified by PCR and
cloned using specific restriction sites. The 350 bp was flanked by
an NsiI and EcoRI site (located at chr4: 114774278–114774628),
and these sites were used for the generation of Scl/Luc/350
construct and deletion of the 350 region from Scl/Luc/+45 (Scl/
Luc/del350) using standard cloning techniques. All constructs
were sequence verified.
Chromatin Immunoprecipitation (ChIP)
The ChIP assays were performed as previously described [12].
Briefly, protein-DNA complexes were cross-linked using 0.4%
formaldehyde followed by cell lysis. Sonication of DNA was
performed using Bioruptor sonicator (Diagenode). The antibodies
used were anti-acetylated histone 3 lysine 9 (Upstate, Millipore),
anti-trimethylated histone 3 lysine 27 (Upstate, Milipore) and anti-
CTCF (Upstate, Millipore).
Microarray hybridization
Hybridization of DNAse1 HSS and ChIP samples to Scl tiling
path microarrays as been described before [21]. Briefly, samples
were labelled with Cy3 and/or Cy5, pooled and hybridized to the
Scl tiling path microarrays using an automated TECAM 400
hybridization station and scanned using a ScanArray 4000
confocal laser-based scanner (Perkin Elmer). Mean spot intensities
were quantified using ScanArray Express (Perkin Elmer) with
background subtraction. Mean spot intensities from replicate
samples were use to generate mean value from each data point.
Data is presented as Cy3/Cy5 ration, where Cy3 represents the
sample and Cy5 the input.
In vivo dimethylsulphate (DMS) footprinting
For in vivo DMS footprinting experiment we performed ligation-
mediated PCR techniques previously published [23]. Briefly, cells
were treated with 0.2% dimethyl sulfate (DMS) in PBS before
DNA extraction and piperidine treatment as described in [24].
Primer sequences are available upon request.
Electrophoretic Mobility Shift Assay (EMSA)
EMSA was performed using standard techniques. The probe
DNA sequence used was the 57 base pair sequence identified from
the DMS footprinting experiments. The probe was end-labeled
using polynucleotide kinase, 30 pmol of oligos, and 2 mCi [c-32P]
ATP. The cold probe of either wild type sequence or mutated
sequence was prepared as standard probe with the exclusion of
2 mCi [c-32P] ATP. The cold probe was added in 106excess as
compared to the hot probe. For supershift the nuclear extract with
probe was incubated with 50 ng of specific CTCF antibody
(Upstate, Millipore).
Insulator Assays
Insulator transfection assays were performed in K562 cells as
described previously [25]. Transfected cells were plated onto a
methylcellulose (StemCell Technology) base medium supplement-
ed with 650 mg/ml of G418 (Invitrogen). All of the DNA
fragments were cloned between the enhancer and the neomycin
resistance gene in the pNI vector. The 1.2 kb fragment containing
the chicken hypersensitive site 24 insulator (cHSIV- genBank
#U78775)) was used as the positive control as previously
published [26]. The 28/29 region, the +45 and the +45del350
were amplified from 416B genomic DNA and cloned into pNI
vector. The +45del350 construct was generated by subcloning
350 bp, from the +45 fragment, into the pNI vector using NsiI and
EcoRI restriction sites. The 350-del57FPR construct was gener-
ated by deleting 57 base pairs of the footprinted region. For the
57 bp footprinted region (57FPR) construct the fragment was
amplified by PCR and cloned into pNI expression vector. The
350MutCTCF construct was generated using a direct mutagenesis
kit (Stratagene).
Transgenic reporter assays
F0 transgenic reporter assays were performed using techniques
previously reported [12]. Briefly, oocytes were injected with
linearized constructs and embryos were harvested at embryonic
day (E) 12.5. Embryos were stained with 5-bromo-4-chloro-3-
indolyl-ß-D-galactopyranoside (X-Gal) for the detection of LacZ
expression as described previously. The SV40-LacZ and the Scl-
LacZ constructs were generated and used previously in transgenic
reporter assays [15]. The +45, +45 del350, and the 350 elements
were subcloned from pNI vector into the pGL2 expression vector
[12]. Genotyping was performed using specific primers for LacZ
gene, available on request. The staining pattern was defined by
microscopic inspection of the embryos. All animal work as been
conduct in agreement with the United Kingdom Home Office
regulations under the ‘‘Animals (scientific procedures) act 1986’’
project licence number PPL 80/2376.
Results
The Scl/Map17 co-regulatory domain is bounded by a
DNase I hypersensitive site 45 kb downstream of the
mouse Scl promoter 1a
We have previously described and validated a high throughput
array-based approach to DNaseI hypersensitive site (HSS)
mapping (ADHM) that uses tiled microarrays to map HSS over
large genomic distances [21]. Using this approach we character-
ized the DNaseI HSS profile across the Scl/Map17 locus in 416B
cells (a mouse haematopoietic progenitor cell line), mouse
embryonic stem cells (mES), and primary mouse thymocytes
(Figure 1A). The 416B cells express Sil, Scl and Map17 but not
Cyp4x, while mES and thymocytes express Sil, low levels of
Murine Scl CTCF-Dependent Insulator Element
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DNaseI HSS is present at the Sil promoter in each of the 3 cell
types, consistent with the ubiquitous expression of this gene. The
central Scl/Map17 co-regulatory domain is prominently accessible
in 416B cells, with clear peaks of accessibility at previously
described regulatory elements of the locus, including the +19 and
+40 Scl haematopoietic enhancers. There is lower level accessi-
bility across this domain in both mES and thymocytes which do
not express Scl, although increased accessibility was noted at
known regulatory elements, such as the +23 neuronal enhancer in
mES cells and +19 enhancer in thymocytes. In all 3 cell types,
there is minimal accessibility over the Cyp4x gene, with the
exception of the promoter region, which remains accessible in
mES cells.
A striking feature of the DNase I profiles from the 3 cell types is
the presence of a 55 kb region of DNase I accessibility spanning
the Scl/Map17 genes. At its 39 end, the extent of this domain is
marked by a DNaseI HSS 45 kb downstream of the Scl promoter
1a (+45 element). This +45 element is DNase I accessible in all cell
types studied, and marks a boundary between the Scl and Map17
genes, which are expressed in developing haematopoietic stem and
progenitor cells, and the Cyp family of genes, which are not.
Analysis of publicly available DNaseI HSS data from the
ENCODE consortium [27] using the UCSC genome browser
[28] shows that the DNaseI HSS site located +45 kb downstream
of the Scl promoter is not haematopoietic specific, but instead
appears to be ubiquitous since it can be observed in a wide range
of mouse tissues including brain, heart and liver (Figure S1B in
Information S1).
The +45 element enhances transcription from a
promoter, but does not direct tissue-specific expression
To investigate whether the +45 region functions as a
transcriptional enhancer, luciferase reporter constructs were
generated using a 1.76 kb genomic fragment encompassing the
complete +45 element and their activity was assessed in 416B cells
hematopoietic progenitor cells (Figure 1B). The presence of the
+45 element significantly increased luciferase activity not only with
the SV40 promoter but also with the endogenous Scl and, to a
lesser extent, the Map17 promoter, indicating that the enhancing
activity of the +45 element is not promoter-specific. Previous
genomic sequence alignments had not identified a peak of
homology corresponding to the +45 element. However, manual
alignment of this region revealed a 350 bp fragment with
significant mouse/human sequence conservation (Figure S2 in
Information S1), and deletion of this 350 bp core sequence
Figure 1. Identification and functional analysis of a novel 1.76 kb Scl element located 45 kb downstream from Scl promoter. (A)
DNaseI hypersensitive profiles across 130 kb (NCBI37/mm9 chr4:114,670,057–114,799,426) of the extended Scl locus in 3 cell types: mouse
haematopoietic progenitors (416B), mouse embryonic stem cells (mES) and primary mouse thymocytes. The location of the 4 genes at the locus are
represented at the top of the figure (Sil, Scl, Map17 and Cyp4x) with direction of transcription indicated by the arrows and translated and
untranslated exons represented by wide and narrow bars respectively. The location of known key regulatory elements is indicated by the red bars (Sil
promoter, Scl promoter, Scl+19, Scl+23, Map17 promoter, Scl+40, and Cyp promoter), and the location of the putative +45 element is indicated with a
dashed red line. The data presented is a representative experiment showing fold enrichment over non-enriched input plotted (log2) against genomic
position. (B) Luciferase activity is increased in 416B cells stably transfected with constructs containing the +45 element (SV/Luc/+45, Map17/Luc/+45
and Scl/Luc/+45) when compared to promoter alone. The 350 bp core region of the +45 element (Scl/Luc/+45del350) is necessary but not sufficient
for full transcriptional enhancement from the Scl/Luc/+45 construct. The left panel represents the constructs diagrammatically. Luciferase activity was
calculated as fold increase over the promoter only construct. The data representing mean +/2 SD relative luciferase activity from 5 independent
experiments, each performed in triplicate. ** indicated p,0.01 compared to promoter alone.
doi:10.1371/journal.pone.0031484.g001
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350 bp core region alone has enhancing activity in luciferase
assays, although not as strong as the full +45 element. In order to
analyze whether the +45 element functions as a cell-type specific
enhancer in vivo, we next studied different constructs containing
the LacZ reporter gene under the control of the SV40 promoter
(SV/LacZ) using transgenic mice reporter assays. The SV40
promoter does not confer tissue-specific expression of the reporter
gene but variable ectopic expression can be observed in F0
transgenic embryos. We have previously used this approach to
characterize a range of Scl regulatory elements that direct Scl
expression to specific developmental domains [10,12,15,17,19].
Constructs containing the element of interest and a SV40P-LacZ
reported cassette were injected in oocytes and F0 embryos were
analysed for LacZ expression at embryonic day (E) 12.5. In the
presence of the +45 element the number of embryos ectopically
expressing LacZ increased significantly (from 24% of transgenic
embryos to 54%, p=0.04) when compared to SV/LacZ alone, but
no consistent tissue-specific expression was observed. No differ-
ence was observed between SV/LacZ and SV/LacZ/+45del350
indicating that the 350 bp core sequence is essential for the
enhancing activity (Table 1). These data raised the possibility that
the +45 element may not function as a tissue-specific transcrip-
tional enhancer in vivo.
The +45 element does not carry the histone marks of a
transcriptional enhancer and is located at the boundary
of the Scl/Map17 genomic region that displays active
and repressive histone marks
To gain further insights into the function of the +45 element, we
investigated the presence of active and repressive histone marks
across the Scl/Map17 co-regulatory domain using chromatin
immunoprecipitation (ChIP; Figure 2). In 416B cells, which
express high levels of Scl and Map17, there were prominent marks
of histone 3 lysine 9 acetylation (H3K9ac) over known active
promoters and enhancers, with lower levels of acetylation over the
same regions in ES cells and thymocytes. The three prominent
peaks of acetylation over the 39 end of the Scl/Map17 co-
regulatory domain in 416B cells correspond to previously
characterized functional cis-elements, the +19 enhancer, the
Map17 promoter (+32) and the +40 enhancer. In contrast, the
+45 element itself did not display H3K9ac in any of the three cell
types studied. To examine the distribution of repressive histone
marks, we repeated ChIP-Chip experiments using an antibody to
trimethylated histone 3 lysine 27 (H3K27me3, Figure 2B). In 416B
cells, H3K27me3 was not detected over the Scl and Map17 genes,
which are both expressed in these cells. However, in mES and
thymocytes, which lack expression of Scl, high levels of
H3K27me3 were detected over this genomic region. This
repressive histone modification did not extend into or beyond
the +45 element. Furthermore, data from the ENCODE
consortium [27] confirms the presence of monomethylated and
trimethylated histone 3 lysine 4 (H3K4me1 and H3K4me3) marks
over the Scl/Map17 locus but not beyond the +45 element in
tissues where Scl and/or Map17 are expressed, like bone marrow
and kidney (Figure S3 in Information S1). Thus, the +45 element
is located at the telomeric boundary of the Scl/Map17 domain
that displays an active chromatin mark in Scl/Map17 expressing
cells and a repressive mark in non-expressing cells.
The 350 bp core fragment of the +45 element contains a
57 bp footprinted region that binds CTCF in vitro and in
vivo
In vivo dimethylsulphate (DMS) footprinting was used to map
DNA-protein interactions across the 350 bp core of the +45
element in 3 different cell types at single nucleotide resolution
(Figure 3A). Samples from BW5147 cells, a T-lymphocyte cell line
that does not express Scl, Map17 or Cyp4X1 [12], 416B cells and
mES cells each showed a prominent 57 bp footprint when
compared to the genomic DNA control. Despite very different
expression levels of Scl and Map17 in the 3 cell types (Figure S1A
in Information S1 and reference [12]), the pattern of in vivo
footprinting at this element was virtually identical, and therefore
concordant with the ubiquitous nature of the DNaseI HSS. The
footprinted region showed a high level of sequence conservation
between mouse, rat and human, and contained a core sequence
highly similar to a recently published CTCF consensus sequence
[29,30].
To investigate whether CTCF binding is responsible for the
footprinting results observed in Figure 3A, we performed
electrophoretic mobility shift assay (EMSA) and ChIP-on-chip
experiments. Using the 57 base pair footprinted region (57FPR) as
the target oligonucleotide, addition of nuclear extract from 416B
haematopoietic progenitor cells resulted in a clear band shift that
was out-competed by excess unlabelled wild type probe, but not by
probe mutated at the proposed CTCF binding site. In addition,
Table 1. The 350 bp core region of the +45 element insulates transgenic constructs and improves tissue-specific expression from
the Scl promoter.
Construct
Total transgenic
embryos LacZ
+ transgenic embryos Expression pattern Embryos with specific LacZ expression
(n) (n) (%) (n) (%)
Sv/Lac 21 5 24 Ectopic 0 0
Sv/Lac/+45 13 7
* 54 Ectopic 0 0
Sv/Lac/+45del350 14 3 21 Ectopic 0 0
Scl/Lac 13 5 38 Brain+Ectopic 1 20
350/Scl/Lac/350 12 8 66 Brain 8
** 100
The total number of F0 transgenic embryos obtained with each construct was determined by PCR using specific primers. Upon ß-galactosidase staining, transgenic
embryos were visually inspected and scored as either LacZ+ or LacZ- and the percentage of LacZ+ embryos calculated.
*p,0.05 compared to SV/LacZ. The expression pattern of Scl/LacZ and 350/Scl/LacZ/350 transgenic embryos is considered ectopic if beyond the mid and hind brain,
the expected expression pattern for the Scl promoter alone.
**p,0.01 compared to Scl/LacZ.
doi:10.1371/journal.pone.0031484.t001
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CTCF antibody (Figure 3B). To confirm whether CTCF binds the
+45 element in vivo, ChIP-on-chip assays were performed with a
CTCF antibody in 416B and mES cells. Representative plots are
shown in figure 3C. In both cell types the most prominent
enrichment with CTCF was observed at the +45 element.
Enrichment was also observed at the Scl and Map17 promoters
in 416B, similar to what was observed in human K562 cells [31].
Analysis of publicly available CTCF ChIP-seq data from the
ENCODE consortium [27] clearly demonstrates CTCF binding to
the +45 element across a wide range of mouse tissues consistent
with the presence of a ubiquitous CTCF site (Figure S4A in
Information S1). Since sequence conservation outside of the
CTCF binding motif is only moderate between human and mouse,
we confirmed that the corresponding human element is also bound
by CTCF in a range of human cell lines (Figure S4B in
Information S1) using available data from the ENCODE
consortium [27]. Together these data strongly suggest that a
CTCF-containing protein complex binds to the core 57 base pair
region of the +45 element in diverse cell type irrespective of Scl/
Map17 expression.
The 1.76 kb +45 element and the smaller core sequences
function as insulators in enhancer blocking assays
We next proceeded to investigate potential insulator function of
the +45 element by inserting it into a construct designed to assess
enhancer-blocking activity in K562 cells. The construct was used
to assess whether DNA placed between an upstream enhancer and
a neomycin resistance gene could function as an enhancer-blocker
and prevent expression of the resistance gene [32].
As shown in Figure 4, the 1.2 kb fragment containing the
chicken beta-globin HSIV (cHSIV) insulator acted as a positive
control, approximately halving the number of drug-resistant
colonies when placed between the upstream enhancer and the
neomycin resistance gene. Similarly, the +45 element had clear
insulator activity, decreasing colony numbers by over 50%
(Figure 4, compare construct cHSIV with +45), whereas a
negative control 2 kb fragment of the Scl locus taken from 8 to
10 kb 59 of the Scl promoter 1a had no effect on colony numbers.
Insulator function was lost when the central 350 bp of the +45
element was removed, while the 350 bp region on its own was as
effective as the complete +45 element. Furthermore, deleting the
Figure 2. ChIP-chip profiles mapping of H3K9ac (A) and H3K27me3 (B) across 150 kb of the extended Scl locus in 3 cell types, 416B
(mouse haematopoietic progenitor cells), mouse embryonic stem cells (mES) and primary mouse thymocytes. The location of the 4
genes at the locus are represented at the top of the figure (Sil, Scl, Map17 and Cyp4x) with direction of transcription indicated by the arrows and
translated and untranslated exons represented by wide and narrow bars respectively. The location of known key regulatory elements is indicated by
the red bars (Sil promoter, Scl promoter, Scl+19, Scl+23, Map17 promoter,Scl+40 and Cyp promoter), and the location of the putative +45 element is
indicated with a dashed red line. Representative experiments showing fold enrichment over non-enriched input plotted (log2) against genomic
position. In the cell types studied, the +45 element is located at a boundary between chromatin domains carrying transcriptionally active and/or
repressive histone marks, while the H3 proteins at the +45 element itself are neither acetylated at H3K9 nor methylated at H3K27.
doi:10.1371/journal.pone.0031484.g002
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e31484Figure 3. In vivo binding of CTCF to 57FPR sequence in haematopoietic progenitor cells. (A) DMS footprinting of the 350 base pair core
region of the +45 element in 3 cell types, BW5147, 416B and mouse ES cells, shows a DNA protein footprint that extends to 57 base pairs in length.
Open circles represent relative protection from DMS-induced methylation compared with naked genomic DNA control, while the closed circle
represents enhancement of DMS-induced methylation. Multiple lanes correspond to different biological replicates. The sequence of the 57 bp
footprinted region (57FPR) is shown with cross-species sequence comparison. The CTCF-consensus binding site from Xie et al is also represented. (B)
EMSA demonstrating a direct interaction between the 57FPR and CTCF protein (lane 2). The interaction is lost by competition with wild type 57FPR
(lane 3), but not by CTCF-mutated 57FPR (lane 4). The arrow indicates the super shifted complex by co-incubation with specific anti-CTCF antibody
(lane 5). The wild type and mutated sequence used for the EMSA are also shown. (C). ChIP-chip profiles mapping CTCF binding across 150 kb of the
extended Scl locus in 2 cell types, 416B (mouse haematopoietic progenitor cells) and mouse embryonic stem cells (mES). The location of the 4 genes
at the locus are represented at the top of the figure (Sil, Scl, Map17 and Cyp4x) with direction of transcription indicated by the arrows and translated
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e31484Figure 4. The +45 element function as an insulator and this activity is dependent on the 57FPR. The left panel represents the different
constructs diagrammatically. Data is presented as K562 colony numbers relative to the control pNI construct containing only the ß-globin HS2
enhancer and the neomycin resistance promoter. The positive control (1.2 kb fragment containing the chicken HSIV insulator) reduces the number of
colonies by 50%, with similar insulation observed from the 1.76 kb +45 element containing the 350 bp core element and the 57FPR. Deletion of
either the 350 bp core from the +45 or deletion of the 57FPR from the 350 bp core, both removed the insulator function of the elements.
Furthermore, mutation of the CTCF-binding site in the 350 bp core element significantly reduced the insulator function of the 350 bp core element.
The data represents the mean 6SD of relative colony numbers from 3 independent experiments each performed in triplicate. * p,0.05, ** p,0.01
when compared to pNI.
doi:10.1371/journal.pone.0031484.g004
and untranslated exons represented by wide and narrow bars respectively. The location of certain known key regulatory elements is indicated by the
red bars (Sil promoter, Scl promoter, Scl+19, Scl+23, Map17 promoter, Scl+40 and Cyp promoter), and the location of the putative +45 element is
indicated with a dashed red line. Representative experiment is showing fold enrichment over non-enriched input plotted (log2) against genomic
position. In the cell types studied, the +45 element is the most highly enriched site for CTCF across the extended Scl locus.
doi:10.1371/journal.pone.0031484.g003
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abolished insulator function, and the 57 bp sequence on its own
exhibited insulator function equivalent to either the 350 bp core or
the entire 1.76 kb +45 element. Mutation of the CTCF site
removed much of the insulator capacity of the 350 bp central
region. Together these data illustrate that the 57 bp footprinted
region is both necessary and sufficient for insulator function of the
+45 element.
The 350 bp core region insulates transgenic constructs
and improves tissue-specific expression from the Scl
promoter
To corroborate the results of our in vitro enhancer-blocking
assay, we developed an in vivo transgenic reporter assay for
insulator function. Extensive transgenic analysis by us and others
has shown that Scl promoter fragments [6,15] as well as Map17
promoter fragments (data not shown) do not possess haematopoi-
etic activity in transgenic mice. Therefore, individual candidate
elements were assessed for their effect on the efficiency and
specificity of expression from LacZ reporter cassettes under the
control of the Scl promoter, which alone drives expression
exclusively in specific regions of the midbrain and hindbrain
[15]. Day 12.5 transgenic embryos were assessed for LacZ
expression and the results are shown in Table 1 and Figure 5.
The presence of the putative insulator sequences increased the
expression efficiency of the LacZ reporter gene in transgenic
embryos from 38% (5/13) to 66% (8/12). In the absence of the
350 bp region, the Scl/LacZ constructs gave rise to ectopic
expression in 4/5 embryos, whereas, in the presence of flanking
350 bp fragments, ectopic expression (i.e, in any other tissue other
than brain) was not seen in any of 8 LacZ expressing embryos
(p,0.01). These data demonstrate that the presence of flanking
350 bp fragments increased the proportion of LacZ expressing
embryos as well as significantly increased the tissue-specific
expression from the Scl promoter in vivo. This is consistent with
the barrier function of an insulator, by preventing position effect
variegation due to integration site of the transgene.
Discussion
We have used array-based DNaseI hypersensitive site mapping
to identify a novel regulatory element 45 kb downstream of the
mouse Scl promoter 1a. We have shown that this element binds
CTCF using both in vivo and in vitro assays, and that protein-DNA
contacts extend to 57 base pairs around a CTCF-consensus
binding site. Furthermore, we have shown that this element
functions as an insulator in enhancer-blocking assays when tested
in haematopoietic cell lines and we have used a novel transgenic
reporter assay to demonstrate that the element can both enhance
the efficiency and specificity of midbrain-specific expression
compared to conventional transgenic analysis. Moreover, analysis
of genome-wide data from the ENCODE consortium confirmed
that the +45 element is a ubiquitous CTCF-bound insulator
region. This element is identified as a DNaseI HSS bound by
CTCF in a variety of Scl/Map17 expressing and non-expressing
tissues, including haematopoietic tissues (bone marrow and
spleen), brain, kidney, liver, heart and lung.
The spatial location of this Scl insulator in relation to
neighbouring genes has clear similarities with other recently
identified insulator sequences. Mapping genome-wide DNase I
sites and chromatin structural elements has confirmed that many
genes appear to be flanked by HSS that appear ubiquitous in a
range of cell types. Data from high throughput protocols have
shown that 86% of ubiquitous DNaseI HSS are within 2 kb of a
transcription start site (TSS), and of the remaining ubiquitous
DNase HSS which are distal to TSS, over 70% have been shown
to bind CTCF in ChIP-chip assays. Furthermore, analysis of the
recently identified CTCF consensus binding site, shared by this Scl
insulator, has shown that more than 80% of evolutionary
conserved sites are greater than 10 kb distal to a TSS. In this
study, we have used DNase-Chip technology to show that the +45
element is a DNase HSS in both Scl-expressing and Scl-non-
expressing cells, and using a range of in vitro and in vivo assays, we
have shown that it has CTCF-dependent insulator function. ChIP-
chip assays for CTCF in human cells have now also identified the
equivalent human sequence as a CTCF binding site [31].
Several insulators have been identified to date, the chicken 59
HSIV being the first identified in vertebrates [33] and by far the
best characterized. This element possesses both enhancer-blocking
and barrier activity, the hallmarks of an insulator element.
Whereas the enhancer-blocking activity is exclusively dependent
of CTCF binding, its barrier activity is dependent of the binding of
transcription factors like USF1 and USF2 [34]. A second insulator
has been identified at the 39 end of the chicken ß-globin locus,
consisting exclusively of a CTCF binding site and possessing
exclusively enhancer-blocking activity [35]. The different functions
Figure 5. The 350 kb core region of the +45 element improves tissue-specific expression of transgenes. The 350/Scl/LacZ/350
transgenic embryos consistently expressed LacZ in mid and hind brain (white arrow), reflecting endogenous expression pattern of Scl in brain, Scl/
LacZ transgenic embryos show ectopic expression (grey arrow). The transgenic constructs are depicted diagrammatically on the left panel, with
photographs of 3 representative transgenic embryos presented on the right.
doi:10.1371/journal.pone.0031484.g005
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The presence of heterochromatin 59 of the chicken ß-globin locus
requires a boundary element to prevent it from spreading over the
locus. The olfactory receptors present 39 of the ß-globin genes are
not expressed in erythroid cells but are expressed in other tissues,
therefore the 39 insulator only need to possess enhancer-blocking
activity. Several other insulators with exclusively enhancer-
blocking activity have been identified like Igf2/H19 ICM which
contains four CTCF binding sites [36,37]. To investigate which
type of function is performed by the +45 element we perform
ChIP-chip for different histone modifications characteristic of
active (H3K9Ac) and repressive (H3K27me3) chromatin. In
expressing cells (416B) the Scl/Map17 locus is clearly marked by
H3K9Ac, not present over the Cyp4X1, while in non-expressed
cells it is marked by the repressive mark H3K27me3. These
experiments indicate that the +45 element is located at the
boundary between chromatin domains, where the Scl/Map17 co-
regulatory domain abuts the Cyp gene family.
Until recently, there has been no clear consensus for the
genomic sequence of the CTCF transcription factor-binding site.
However, using high throughput techniques a new consensus
CTCF sequence has been proposed. Intriguingly, a number of
well-characterised insulators such as the chicken HSIV, the mouse
ß-globin HS2 and the human myb HS2 have relatively little
sequence similarity [38], and display only partial similarities to the
newly identified consensus sequence. In contrast, the +45 CTCF
site that we have functionally mapped in this study shows tight
sequence conservation with the new CTCF-consensus sequence,
yet was not identified through CTCF binding site consensus
mapping. This study therefore provides an independent functional
verification of the new CTCF consensus sequence.
The CTCF protein is a large 11 zinc-finger complex that has
been shown to contact DNA over many base pairs at other
previously-mapped insulator elements [39]. In this study we have,
for the first time, used in vivo DMS footprinting to map the extent
of the protein-DNA interactions at a CTCF-dependent insulator.
This shows that in vivo, the protein-DNA interaction extends to 57
base pairs of DNA, i.e. beyond the CTCF-consensus binding
sequence, suggesting that the structure of DNA surrounding the
consensus binding site is likely to play a key role in the CTCF
protein-DNA interaction. Moreover we demonstrate that the
57 bp core fragment is both necessary and sufficient for insulator
function in vitro.
In order to further dissect the +45 insulator function we
performed the classic enhancer-blocking assay in haematopoietic
cell lines. Introduction of the full +45 element, the 350 bp core
region or the 57FPR between the enhancer and the Neo reporter
gene lead to a reduction in Neo resistant colonies, similarly to the
1.2 kb cHSIV insulator. The number of colonies was unaltered or
even increased when the CTCF binding site in the +45 element
was deleted or mutated (del350, 350del57FPR and 350mutCTCF)
indicating the CTCF-dependent enhancer-blocking activity. This
may be explained by the fact that different cell lines were used for
these assays (murine 416B and human K562). To check the
insulator function of the +45 element in vivo, we elected to develop
a transgenic mouse reporter model of insulator function. Using this
approach we have demonstrated that the +45 insulator can be
used to improve both the frequency of transgene expression (i.e.
the proportion of transgenic embryos which express LacZ) and
reduces ectopic transgene expression. The Scl promoters drive
expression to the brain but not to haematopoietic tissues [15].
Flanking the Scl promoter driven Lacz reporter gene cassette with
the +45 element very significantly reduced reporter gene
expression in tissues other than brain, the staining pattern
expected for the Scl promoter. The discrepancy of tissue types
used for the in vitro (haematopoietic) and in vivo (brain) assays was
necessitated by the restricted in vivo activity of Scl and Map17
promoters, none of which drive expression in haematopoietic cells
in vivo when assayed in transgenic mice. Taken together, these data
raise the possibility that the +45 element could be a useful tool
allowing effective insulation of transgenic constructs from adjacent
chromatin.
In conclusion, we have presented data that identifies and
functionally defines a putative novel insulator sequence located
45 kb upstream of the Scl transcription start site at the boundary
of chromatin domains. Our results suggest that the +45 element
functions as a CTCF-dependent insulator, that may prevent
inappropriate activation both of the Cyp genes during haemato-
poietic differentiation and also of Scl and Map17 during hepatic
development.
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